NCT04666038 2026-04-24BRUIN CLL-321Eli Lilly and CompanyPhase 3 Active not recruiting238 enrolled 17 charts 1 FDA
NCT03133221 2025-06-271630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell TransplantationUniversity of Maryland, BaltimorePhase 2 Completed17 enrolled 10 charts